Cargando…
Wld(S )but not Nmnat1 protects dopaminergic neurites from MPP(+ )neurotoxicity
BACKGROUND: The Wld(S )mouse mutant ("Wallerian degeneration-slow") delays axonal degeneration in a variety of disorders including in vivo models of Parkinson's disease. The mechanisms underlying Wld(S )-mediated axonal protection are unclear, although many studies have attributed Wld...
Autores principales: | Antenor-Dorsey, Jo Ann V, O'Malley, Karen L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322348/ https://www.ncbi.nlm.nih.gov/pubmed/22315973 http://dx.doi.org/10.1186/1750-1326-7-5 |
Ejemplares similares
-
Wld(S) protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice
por: Conforti, Laura, et al.
Publicado: (2009) -
Wld(S) requires Nmnat1 enzymatic activity and N16–VCP interactions to suppress Wallerian degeneration
por: Avery, Michelle A., et al.
Publicado: (2009) -
Does axonopathy play a role in Parkinson's disease?
por: O’Malley, Karen L, et al.
Publicado: (2012) -
miR‐30b protects nigrostriatal dopaminergic neurons from MPP(+)‐induced neurotoxicity via SNCA
por: Shen, Yu‐fei, et al.
Publicado: (2020) -
Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)